Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd./ADR
SKBBYDrugs in Pipeline
53
Phase 3 Programs
29
Upcoming Catalysts
42
Next Catalyst
May 15, 2026
16dMarket Overview
Stock performance and key metrics
42 upcoming, 0 past
Wujia Yizhi granules
Alzheimer's Dementia
Pemetrexed
Non-small Cell Lung Cancer
SI-B001
Non-small Cell Lung Adenocarcinoma
BL-B01D1
Advanced Biliary Tract Cancer
Capecitabine
Metastatic Breast Cancer
Docetaxel or Paclitaxel
Urothelial Carcinoma
Eribulin
HR+HER2- Breast Cancer
Osimertinib
Non-Small Cell Lung Cancer
T-DM1
HER2-positive Breast Cancer
Docetaxel
Non-small Cell Lung Cancer
Paclitaxel
Head and Neck Squamous Cell Carcinoma
SKB264
Metastatic Breast Cancer
Vinorelbine
Triple-Negative Breast Cancer
BL-M07D1
Her2-positive/Low-expression Urinary and Digestive Tract Tumors
A166
HER2-positive Breast Cancer
Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
Non-small Cell Lung Cancer
KL-A167
Nasopharyngeal Carcinoma
Double blind control period A140
Metastatic Colorectal Cancer
Nab-paclitaxel
Triple Negative Breast Cancer
Topotecan
Small Cell Lung Cancer
HSK3486
Sedation or Anesthesia
Capecitabine, Eribulin, Gemcitabine, Paclitaxel, or Albumin paclitaxel
HER2-low Breast Cancer
Propofol
Colonoscopy
Irinotecan
Esophageal Squamous Cell Carcinoma
gemcitabine
Nasopharyngeal Carcinoma
KN035 plus Gemcitabine & oxaliplatin
Biliary Tract Neoplasms
Investigator's choice of chemotherapy
Gastric Adenocarcinoma
Pemetrexed+Cisplatin or Carboplatin
Non-small Cell Lung Cancer
Carboplatin
Non-squamous Non-small Cell Lung Cancer
Lenvatinib + Envafolimab
Solid Tumors
KL590586 Capsule
Advanced Solid Tumor
SI-B003
Esophageal Cancer
Osimertinib Mesylate Tablets
Non-small Cell Lung Cancer
SKB571 for injection
Lung Cancer (Non-Small Cell)
BL-M02D1
Non-small Cell Lung Cancer
Test product HY0001a for injection
Solid Tumor
KN035
Solid Tumor
GNC-035
Non-hodgkin's Lymphoma
PD-1 monoclonal antibody
Extensive-stage Small-cell Lung Cancer
Envafolimab+Lenvatinib
Advanced Endometrial Cancer
AP or TP
Non Small Cell Lung Cancer
PD-1
Urothelial Carcinoma
Axitinib
Renal Cancer
SKB500 Powder for Injection
Small Cell Lung Cancer
Lenvatinib
Advanced Hepatocellular Carcinoma
Test product: HYP-2090PTSA
Safety
GNC-038
Diffuse Large B-cell Lymphoma
HY05350 for injection
Advanced Solid Tumor
PRT-064040 nasal spray
Migraine
SKB518
Lung Carcinoma
KL-A167 Injection
Nasopharyngeal Carcinoma
Envafolimab
Solid Tumor
BL-B01D1 for Injection
Recurrent Glioblastoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Wujia Yizhi granules | Phase 3 | Alzheimer's Dementia | - | - |
Pemetrexed | Phase 3 | Non-small Cell Lung Cancer | - | - |
SI-B001 | Phase 3 | Non-small Cell Lung Adenocarcinoma | - | - |
BL-B01D1 | Phase 3 | Advanced Biliary Tract Cancer | - | - |
Capecitabine | Phase 3 | Metastatic Breast Cancer | - | - |
Docetaxel or Paclitaxel | Phase 3 | Urothelial Carcinoma | - | - |
Eribulin | Phase 3 | HR+HER2- Breast Cancer | - | - |
Osimertinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
T-DM1 | Phase 3 | HER2-positive Breast Cancer | - | - |
Docetaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
Paclitaxel | Phase 3 | Head and Neck Squamous Cell Carcinoma | - | - |
SKB264 | Phase 3 | Metastatic Breast Cancer | - | - |
Vinorelbine | Phase 3 | Triple-Negative Breast Cancer | - | - |
BL-M07D1 | Phase 3 | Her2-positive/Low-expression Urinary and Digestive Tract Tumors | - | - |
A166 | Phase 3 | HER2-positive Breast Cancer | - | - |
Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection | Phase 3 | Non-small Cell Lung Cancer | - | - |
KL-A167 | Phase 3 | Nasopharyngeal Carcinoma | - | - |
Double blind control period A140 | Phase 3 | Metastatic Colorectal Cancer | - | - |
Nab-paclitaxel | Phase 3 | Triple Negative Breast Cancer | - | - |
Topotecan | Phase 3 | Small Cell Lung Cancer | - | - |
HSK3486 | Phase 3 | Sedation or Anesthesia | - | - |
Capecitabine, Eribulin, Gemcitabine, Paclitaxel, or Albumin paclitaxel | Phase 3 | HER2-low Breast Cancer | - | - |
Propofol | Phase 3 | Colonoscopy | - | - |
Irinotecan | Phase 3 | Esophageal Squamous Cell Carcinoma | - | - |
gemcitabine | Phase 3 | Nasopharyngeal Carcinoma | - | - |
KN035 plus Gemcitabine & oxaliplatin | Phase 3 | Biliary Tract Neoplasms | - | - |
Investigator's choice of chemotherapy | Phase 3 | Gastric Adenocarcinoma | - | - |
Pemetrexed+Cisplatin or Carboplatin | Phase 3 | Non-small Cell Lung Cancer | - | - |
Carboplatin | Phase 3 | Non-squamous Non-small Cell Lung Cancer | - | - |
Lenvatinib + Envafolimab | Phase 2 | Solid Tumors | - | - |
KL590586 Capsule | Phase 2 | Advanced Solid Tumor | - | - |
SI-B003 | Phase 2 | Esophageal Cancer | - | - |
Osimertinib Mesylate Tablets | Phase 2 | Non-small Cell Lung Cancer | - | - |
SKB571 for injection | Phase 2 | Lung Cancer (Non-Small Cell) | - | - |
BL-M02D1 | Phase 2 | Non-small Cell Lung Cancer | - | - |
Test product HY0001a for injection | Phase 2 | Solid Tumor | - | - |
KN035 | Phase 2 | Solid Tumor | - | - |
GNC-035 | Phase 2 | Non-hodgkin's Lymphoma | - | - |
PD-1 monoclonal antibody | Phase 2 | Extensive-stage Small-cell Lung Cancer | - | - |
Envafolimab+Lenvatinib | Phase 2 | Advanced Endometrial Cancer | - | - |
AP or TP | Phase 2 | Non Small Cell Lung Cancer | - | - |
PD-1 | Phase 2 | Urothelial Carcinoma | - | - |
Axitinib | Phase 2 | Renal Cancer | - | - |
SKB500 Powder for Injection | Phase 2 | Small Cell Lung Cancer | - | - |
Lenvatinib | Phase 2 | Advanced Hepatocellular Carcinoma | - | - |
Test product: HYP-2090PTSA | Phase 2 | Safety | - | - |
GNC-038 | Phase 2 | Diffuse Large B-cell Lymphoma | - | - |
HY05350 for injection | Phase 2 | Advanced Solid Tumor | - | - |
PRT-064040 nasal spray | Phase 2 | Migraine | - | - |
SKB518 | Phase 2 | Lung Carcinoma | - | - |
KL-A167 Injection | Phase 2 | Nasopharyngeal Carcinoma | - | - |
Envafolimab | Phase 2 | Solid Tumor | - | - |
BL-B01D1 for Injection | Phase 2 | Recurrent Glioblastoma | - | - |